The aim of this study is to: * clarify whether macrophage imaging using ferucarbotran is able to delineate the region of myocardial infarction as accurate as gadolinium-based necrosis/fibrosis imaging; * identify possible differences in infarct imaging using ferucarbotran for macrophage imaging compared to necrosis/fibrosis imaging with gadolinium-based compounds; and * evaluate which MRI pulse-sequences maximise sensitivity for macrophage imaging with ferucarbotran in the setting of acute myocardial infarction.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
20
single time intravenous bolus injection of a contrast agent
Robert-Bosch-Krankenhaus, Division of Cardiology
Stuttgart, Germany
Extent of myocardial infarction (as demonstrated with gadolinium-based necrosis/ fibrosis imaging compared to macrophage imaging using ferucarbotran)
Time frame: within 5 - 15 days after myocardial infarction
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.